Aprea Therapeutics, Inc. (APRE)

Financing Cash Flow

-$1.94M

Quarterly · Period ending: · USD

APRE logo

APRE Financing Cash Flow

Latest reported-$1.94M
APRE Quarterly Cash from Financing ($0.00 → -$1.94M)
High-resolution chart · PNG

APRE financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-1,937,707
34,624,149
3,841,570
357,940
384,879
55,849
134,405
-1,155
-21,060
14,709,705
0
0
0
5,139,990
98,526
584,447
0
0
1,660,042
86,970
0
0
0
9,141
121,426
29,523
85,568,591
0
188,826
5,432,654
56,365,327
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.